Celrixafor Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Plerixafor (24mg)
Overview Celrixafor Injection
Autologous stem cell transplantation, a procedure involving the extraction, treatment, and reintroduction of blood cells following chemotherapy or radiation therapy for specific cancers, utilizes Celrixafor Injection. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. While benefits might not be immediately apparent (weeks or months may pass), discontinue use only as directed. Common side effects include nausea, diarrhea, and injection site reactions; report any concerning symptoms to your doctor for potential mitigation strategies. Prior to treatment, inform your physician of any pre-existing conditions such as abnormal blood cell counts or kidney issues, and any concurrent medications, especially those for infections. Interaction with other drugs is possible, so disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy or breastfeeding; reliable contraception for both partners is crucial throughout treatment to prevent conception.
Uses of Celrixafor Injection
Self-infused stem cell transplantation
Major Benefits of Celrixafor Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
Common Side effects of Celrixafor Injection:
- Nausea
- Diarrhea
- Injection site reaction
How to use Celrixafor Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Celrixafor Injection works:
Celrixafor Injection facilitates hematopoietic stem cell mobilization. Its mechanism of action involves inducing the translocation of specific blood cells from bone marrow into the bloodstream, enabling their subsequent collection for transplantation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of Celrixafor Injection with alcohol is unknown; therefore, physician consultation is advised before combining the two.
PregnancyCONSULT YOUR DOCTOR
Administering Celrixafor Injection during pregnancy is contraindicated due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The administration of Celrixafor Injection while breastfeeding is likely inadvisable. Scant clinical evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
Celrixafor Injection's impact on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Celrixafor Injection to individuals with impaired renal function. Dosage modification of Celrixafor Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Celrixafor Injection use in patients with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Celrixafor Injection :
NA
Facts to Know About Celrixafor Injection
| Label | Value |
|---|---|
| Chemical Classification | Benzylamines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Agent for mobilizing hematopoietic stem cells |
3,018 People bought this recently